“…The methods developed to recruit endogenous BMSC and deliver exogenous BMSC systemically or locally ( Figure 1 ) include cell-free strategies, magnetic cell labeling and tissue specific targeting, aptamer-nanoparticles, small bioactive molecules, injectable agents, the use of platelet-rich plasma (PRP) or bone marrow aspirates, BMSC secreted exosomes, and bio-engineered scaffold approaches, including three dimensional (3D) bioprinting (bioinks) [ 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 ].…”